Concepedia

Charles F. Schwender

CF

30

Publications

1.3K

Citations

20

H-Index

1970

Active since

Affiliations

Johnson & Johnson (United States)(Current)

KalVista Pharmaceuticals (United States)

Gaertner (United States)

Charles F. Schwender is an author at Johnson & Johnson (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1970–2000

30

Publications

30

Enzyme inhibitors. 26. Bridging hydrophobic and hydrophilic regions on adenosine deaminase with some 9-(2-hydroxy-3-alkyl)adenines

Howard J. Schaeffer, Charles F. Schwender · Journal of Medicinal Chemistry · 1974 · 295 citations

, , +17

DNA gyrase inhibitory and antibacterial activity of some flavones(1)

Kwasi A. Ohemeng, Charles F. Schwender, Kwung P. Fu et al. · Bioorganic & Medicinal Chemistry Letters · 1993 · 199 citations

, , +3

Phosphatase inhibitors—III. Benzylaminophosphonic acids as potent inhibitors of human prostatic acid phosphatase

Scott A. Beers, Charles F. Schwender, Deborah A. Loughney et al. · Bioorganic & Medicinal Chemistry · 1996 · 87 citations

, , +7

Soybean lipoxygenase inhibition by nonsteroidal antiinflammatory drugs

Jagadish C. Sircar, Charles F. Schwender, Elizabeth A. Johnson · Prostaglandins · 1983 · 83 citations

, , +5

Inhibition of soybean lipoxygenase by sulfasalazine and 5-aminosalicylic acid: a possible mode of action in ulcerative colitis

Jagadish C. Sircar, Charles F. Schwender, Mary E. Carethers · Biochemical Pharmacology · 1983 · 72 citations

, , +9

Rows per page

1–5 of 30